Abdominal Drainage Tubes Market by Product (Active, Passive), Application (Cardiac & Thoracic Surgery, General Surgery, Obstetric/Gynecological Surgery), End-User - Global Forecast 2024-2030

Abdominal Drainage Tubes Market by Product (Active, Passive), Application (Cardiac & Thoracic Surgery, General Surgery, Obstetric/Gynecological Surgery), End-User - Global Forecast 2024-2030


The Abdominal Drainage Tubes Market size was estimated at USD 897.53 million in 2023 and expected to reach USD 950.75 million in 2024, at a CAGR 6.14% to reach USD 1,362.59 million by 2030.

Abdominal drainage tubes are medical devices designed for the removal of fluids that have either accumulated or are secreted in the abdominal area, a common need following surgery or due to various medical conditions such as abscesses, peritonitis, or post-operative complications. These tubes facilitate the drainage of pus, blood, bile, or other fluids, minimizing the risk of infection and promoting faster recovery of the patient. The rise in the number of abdominal surgeries, including organ transplants and cancer removal, directly correlates with the increased need for abdominal drainage tubes. The global increase in the aging population, who are more susceptible to conditions requiring abdominal drainage, further creates an urgent need for abdominal drainage kits and tubes. The complexities associated with handling the tubes, coupled with the need for accurate, delicate, and frequent maintenance, create complications for the market of abdominable drainage tubes. Furthermore, the possibility of leakage or contamination and other operational failures of the tubes raises concerns about the reliability and safety of the device or system. However, key players are exploring advancements in material sciences and developing more advanced, patient-friendly tubes to provide safer and more accurate drainage solutions. Collaborating with healthcare providers for clinical trials and research can lead to product enhancements and increased credibility among medical professionals.

Regional Insights

In the Americas, particularly in the United States and Canada, the need for abdominal drainage tubes is driven by the growing incidence of abdominal surgeries and trauma cases. In the U.S., advancements in healthcare infrastructure and a strong emphasis on infection control within medical facilities support market growth. The adoption of the latest technologies and the presence of key players in the region encourage innovation. Patents pertaining to design improvements for easier insertion and better fluid collection are often registered here. EU countries exhibit a significant need for abdominal drainage tubes due to the rising surgical procedures and an aging population. Stringent EU medical device regulations ensure high standards of product quality and safety, influencing consumer trust and preference for advanced drainage solutions. Health care systems across Europe focus on reducing hospital stay durations, propelling the need for effective post-operative care devices such as abdominal drainage tubes. Recent initiatives in the EU include funding for projects aimed at enhancing medical device innovation, including drainage tubes with improved biocompatibility and functionalities. The Asia Pacific region, especially China, Japan, and India, presents a dynamic market for abdominal drainage tubes. Factors such as increasing government healthcare expenditure, a rapidly growing patient base, and the surge in surgical interventions fuel the need for abdominal drainage kits and tubes. In China and India, the emphasis on healthcare reforms and improving hospital infrastructure offers significant opportunities for market expansion. The latest patents in this region often focus on materials that reduce infection risks and enhance patient comfort. Japan's well-established healthcare system and focus on high-quality medical devices foster a market for technologically advanced abdominal drainage tubes.

Market Insights

Market Dynamics

The market dynamics represent an ever-changing landscape of the Abdominal Drainage Tubes Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers
  • Growing incidences of chronic diseases and abdominal surgeries across the world
  • Approvals for abdominal drainage kits and tubes and government support for improving access to healthcare facilities
Market Restraints
  • Complexities in handling abdominal drainage tubes and lack of skilled personnel
Market Opportunities
  • Ongoing advancements to improve the performance and safety of abdominal drainage tubes
  • Integration of telehealth and digital health services for patient monitoring
Market Challenges
  • Possibility of leakage and technical or operational failures
Market Segmentation Analysis
  • Product: Preference for active systems due to their efficiency in drainage and lower risk of infection
  • End-User: Emerging utilization of abdominal drainage tubes in general surgery to mitigate post-operative complications
Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Abdominal Drainage Tubes Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Abdominal Drainage Tubes Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Merit Medical's (MMSI) Aspira Bottle to Boost At-Home Services

Merit Medical Systems, Inc. (MMSI) recently unveiled the Aspira Bottle, representing an advancement for the Aspira Drainage System. This innovation is designed to facilitate the management of chronic conditions such as recurrent and symptomatic pleural effusions and malignant ascites, common in end-stage cancer patients. The Aspira Drainage System, including the newly introduced Aspira Bottle, offers a dignified and compassionate solution, enabling patients to manage fluid buildup from the comfort of their own homes. This system aims to reduce the necessity for frequent hospital visits and also enhances the quality of life for patients by offering a user-friendly, at-home drainage option.

AngioDynamics Receives FDA Breakthrough Device Designation for the AngioVac System for the Non-Surgical Removal of Right Heart Vegetation

AngioDynamics, Inc., a player in medical technology with a focus on enhancing vascular health, received a Breakthrough Device designation from the U.S. Food and Drug Administration (FDA) for its AngioVac System. The AngioVac System, an innovative aspiration system integrated within a venous drainage cannula, facilitates the removal of thrombi or emboli during a six-hour maximum extracorporeal bypass procedure. It distinguishes itself by efficiently extracting thrombus and embolic debris across major vessels, including the iliofemoral vein, inferior vena cava (IVC), superior vena cava (SVC), and right heart, while significantly reducing blood loss by recirculating blood via the AngioVac's venovenous bypass circuit.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Abdominal Drainage Tubes Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Abdominal Drainage Tubes Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Advin Health Care, B. Braun SE, Becton, Dickinson and Company, Boen Healthcare Co., Ltd, Cardinal Health, Inc., Cook Group Incorporated, GPC Medical Ltd, Iskus Health Ltd, Johnson & Johnson Services, Inc, La-med Healthcare Pvt. Ltd., Medline Industries Ltd, Medline Industries, LP., Medtronic, plc, Medzell, Merit Medical Systems, Inc., Omex Medical Technology, Pfm Medical Gmbh, Redax S.P.A, Rocket Medical plc, Romsons Prime Pvt Ltd., Smith & Nephew plc, Sterimed Group, Suru International Pvt. Ltd., and Teleflex Incorporated.

Market Segmentation & Coverage

This research report categorizes the Abdominal Drainage Tubes Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product
  • Active
  • Jackson-Pratt Drain
  • Penrose Drain
  • Passive
  • Application
  • Cardiac & Thoracic Surgery
  • General Surgery
  • Obstetric/Gynecological Surgery
  • Orthopedics Surgery
  • End-User
  • Ambulatory Surgery Centers
  • Hospitals
  • Region
  • Americas
  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
  • California
  • Florida
  • Illinois
  • New York
  • Ohio
  • Pennsylvania
  • Texas
  • Asia-Pacific
  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Vietnam
  • Europe, Middle East & Africa
  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom


Please Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing incidences of chronic diseases and abdominal surgeries across the world
5.1.1.2. Approvals for abdominal drainage kits and tubes and government support for improving access to healthcare facilities
5.1.2. Restraints
5.1.2.1. Complexities in handling abdominal drainage tubes and lack of skilled personnel
5.1.3. Opportunities
5.1.3.1. Ongoing advancements to improve the performance and safety of abdominal drainage tubes
5.1.3.2. Integration of telehealth and digital health services for patient monitoring
5.1.4. Challenges
5.1.4.1. Possibility of leakage and technical or operational failures
5.2. Market Segmentation Analysis
5.2.1. Product: Preference for active systems due to their efficiency in drainage and lower risk of infection
5.2.2. End-User: Emerging utilization of abdominal drainage tubes in general surgery to mitigate post-operative complications
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Abdominal Drainage Tubes Market, by Product
6.1. Introduction
6.2. Active
6.3. Passive
7. Abdominal Drainage Tubes Market, by Application
7.1. Introduction
7.2. Cardiac & Thoracic Surgery
7.3. General Surgery
7.4. Obstetric/Gynecological Surgery
7.5. Orthopedics Surgery
8. Abdominal Drainage Tubes Market, by End-User
8.1. Introduction
8.2. Ambulatory Surgery Centers
8.3. Hospitals
9. Americas Abdominal Drainage Tubes Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Abdominal Drainage Tubes Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Abdominal Drainage Tubes Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. Merit Medical's (MMSI) Aspira Bottle to Boost At-Home Services
12.3.2. AngioDynamics Receives FDA Breakthrough Device Designation for the AngioVac System for the Non-Surgical Removal of Right Heart Vegetation
12.4. Strategy Analysis & Recommendation
13. Competitive Portfolio
13.1. Key Company Profiles
13.2. Key Product Portfolio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings